Grading of diabetic retinopathy

Michael Larsen, Wael Soliman, Timothy S. Kern, Susanne Mohr, Aniz Girach, Donald Fong, Gabriele E. Lang, Horst Helbig, Antonia M. Joussen, Anthony P. Adamis, Barrett Katz, Diana V. Do, Quan Don Nguyen, Syed Mahmood Shah, Julia A. Haller

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The grading of diabetic retinopathy is based on the concept that a hierarchy of stages can be defined, where the higher the grade, the higher the risk of suffering visual loss. The grading scale reflects the natural course of the disease in its unrelenting and most devastating form. In reality, diabetic retinopathy can regress both spontaneously and after therapeutic intervention. To construct or validate a grading scale, rates of progression to visual loss or another endpoint that is meaningful to the patient must be measured. Grading scales constructed for scientific and regulatory purposes, such as the study of new interventions, are made with the purpose of achieving maximum sensitivity for change in retinopathy. Interventional trials may then result in selected grades being validated and found useful for guiding interventions such as photocoagulation for proliferative diabetic retinopathy or diabetic macular edema. The timely identification of patients who reach interventional thresholds is the purpose subserved by simpler grading scales used in clinical screening practice.

Original languageEnglish (US)
Title of host publicationRetinal Vascular Disease
PublisherSpringer Berlin Heidelberg
Pages291-391
Number of pages101
ISBN (Print)9783540295419
DOIs
StatePublished - 2007

Fingerprint

Diabetic Retinopathy
Macular Edema
Light Coagulation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Larsen, M., Soliman, W., Kern, T. S., Mohr, S., Girach, A., Fong, D., ... Haller, J. A. (2007). Grading of diabetic retinopathy. In Retinal Vascular Disease (pp. 291-391). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-29542-6_19

Grading of diabetic retinopathy. / Larsen, Michael; Soliman, Wael; Kern, Timothy S.; Mohr, Susanne; Girach, Aniz; Fong, Donald; Lang, Gabriele E.; Helbig, Horst; Joussen, Antonia M.; Adamis, Anthony P.; Katz, Barrett; Do, Diana V.; Nguyen, Quan Don; Shah, Syed Mahmood; Haller, Julia A.

Retinal Vascular Disease. Springer Berlin Heidelberg, 2007. p. 291-391.

Research output: Chapter in Book/Report/Conference proceedingChapter

Larsen, M, Soliman, W, Kern, TS, Mohr, S, Girach, A, Fong, D, Lang, GE, Helbig, H, Joussen, AM, Adamis, AP, Katz, B, Do, DV, Nguyen, QD, Shah, SM & Haller, JA 2007, Grading of diabetic retinopathy. in Retinal Vascular Disease. Springer Berlin Heidelberg, pp. 291-391. https://doi.org/10.1007/978-3-540-29542-6_19
Larsen M, Soliman W, Kern TS, Mohr S, Girach A, Fong D et al. Grading of diabetic retinopathy. In Retinal Vascular Disease. Springer Berlin Heidelberg. 2007. p. 291-391 https://doi.org/10.1007/978-3-540-29542-6_19
Larsen, Michael ; Soliman, Wael ; Kern, Timothy S. ; Mohr, Susanne ; Girach, Aniz ; Fong, Donald ; Lang, Gabriele E. ; Helbig, Horst ; Joussen, Antonia M. ; Adamis, Anthony P. ; Katz, Barrett ; Do, Diana V. ; Nguyen, Quan Don ; Shah, Syed Mahmood ; Haller, Julia A. / Grading of diabetic retinopathy. Retinal Vascular Disease. Springer Berlin Heidelberg, 2007. pp. 291-391
@inbook{ea57799028d24c8280015898ddc2dc01,
title = "Grading of diabetic retinopathy",
abstract = "The grading of diabetic retinopathy is based on the concept that a hierarchy of stages can be defined, where the higher the grade, the higher the risk of suffering visual loss. The grading scale reflects the natural course of the disease in its unrelenting and most devastating form. In reality, diabetic retinopathy can regress both spontaneously and after therapeutic intervention. To construct or validate a grading scale, rates of progression to visual loss or another endpoint that is meaningful to the patient must be measured. Grading scales constructed for scientific and regulatory purposes, such as the study of new interventions, are made with the purpose of achieving maximum sensitivity for change in retinopathy. Interventional trials may then result in selected grades being validated and found useful for guiding interventions such as photocoagulation for proliferative diabetic retinopathy or diabetic macular edema. The timely identification of patients who reach interventional thresholds is the purpose subserved by simpler grading scales used in clinical screening practice.",
author = "Michael Larsen and Wael Soliman and Kern, {Timothy S.} and Susanne Mohr and Aniz Girach and Donald Fong and Lang, {Gabriele E.} and Horst Helbig and Joussen, {Antonia M.} and Adamis, {Anthony P.} and Barrett Katz and Do, {Diana V.} and Nguyen, {Quan Don} and Shah, {Syed Mahmood} and Haller, {Julia A.}",
year = "2007",
doi = "10.1007/978-3-540-29542-6_19",
language = "English (US)",
isbn = "9783540295419",
pages = "291--391",
booktitle = "Retinal Vascular Disease",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Grading of diabetic retinopathy

AU - Larsen, Michael

AU - Soliman, Wael

AU - Kern, Timothy S.

AU - Mohr, Susanne

AU - Girach, Aniz

AU - Fong, Donald

AU - Lang, Gabriele E.

AU - Helbig, Horst

AU - Joussen, Antonia M.

AU - Adamis, Anthony P.

AU - Katz, Barrett

AU - Do, Diana V.

AU - Nguyen, Quan Don

AU - Shah, Syed Mahmood

AU - Haller, Julia A.

PY - 2007

Y1 - 2007

N2 - The grading of diabetic retinopathy is based on the concept that a hierarchy of stages can be defined, where the higher the grade, the higher the risk of suffering visual loss. The grading scale reflects the natural course of the disease in its unrelenting and most devastating form. In reality, diabetic retinopathy can regress both spontaneously and after therapeutic intervention. To construct or validate a grading scale, rates of progression to visual loss or another endpoint that is meaningful to the patient must be measured. Grading scales constructed for scientific and regulatory purposes, such as the study of new interventions, are made with the purpose of achieving maximum sensitivity for change in retinopathy. Interventional trials may then result in selected grades being validated and found useful for guiding interventions such as photocoagulation for proliferative diabetic retinopathy or diabetic macular edema. The timely identification of patients who reach interventional thresholds is the purpose subserved by simpler grading scales used in clinical screening practice.

AB - The grading of diabetic retinopathy is based on the concept that a hierarchy of stages can be defined, where the higher the grade, the higher the risk of suffering visual loss. The grading scale reflects the natural course of the disease in its unrelenting and most devastating form. In reality, diabetic retinopathy can regress both spontaneously and after therapeutic intervention. To construct or validate a grading scale, rates of progression to visual loss or another endpoint that is meaningful to the patient must be measured. Grading scales constructed for scientific and regulatory purposes, such as the study of new interventions, are made with the purpose of achieving maximum sensitivity for change in retinopathy. Interventional trials may then result in selected grades being validated and found useful for guiding interventions such as photocoagulation for proliferative diabetic retinopathy or diabetic macular edema. The timely identification of patients who reach interventional thresholds is the purpose subserved by simpler grading scales used in clinical screening practice.

UR - http://www.scopus.com/inward/record.url?scp=84865708242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865708242&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-29542-6_19

DO - 10.1007/978-3-540-29542-6_19

M3 - Chapter

AN - SCOPUS:84865708242

SN - 9783540295419

SP - 291

EP - 391

BT - Retinal Vascular Disease

PB - Springer Berlin Heidelberg

ER -